ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001216.1|Splenocin_1 # 1 # 522 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.736	BGC0001216.1|Splenocin_1 	1	522	-	Loose	500	29.261	OXA-145	23.53	3001804	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAACACCGCGCACGAACTGCCCGCCCCCGTGGACCGGTTGCTGCCGCGGGCGAGGGCGGGCGACGAGCAGGCGATGAACGACCTGCTGCTGCACATCACCCCCTACGTCACCCGCGTCTGCCGCTCGGTCGCCCACGACAACGGCTCCGACGCCCGGCAGGAGGCGCTCCTCGCGATCTACCGCGGCCTGCCGGGCCTGCGGGAGCCCGCTGCCTTCTACGGCTGGGTCCGCTCGGTCACCGTGCGGGAGGCGGTGCGCACGGCCAGGCGCCTGGGCCGCGAGACGACGAGCCCCGAGGTGGACTCGCGGCACGAGCCCCACTCGCTCGACGCCGTCCACATCAACGACGTCCTGGACCGCATGTCCGAGGCCCACCGACAGGTGCTGACCCTTCGCGTGTACGGCCTGAACGAGGTGGAGATGGCCGAGACCCTCGCCCTCCCCGTCGGCACGGTCCGCTCCCGGCTCCACCGGGCCCGCCGCCGCTTCCAGGAGGCATGGCAGCCCACCGCCGCCTGA	MNTAHELPAPVDRLLPRARAGDEQAMNDLLLHITPYVTRVCRSVAHDNGSDARQEALLAIYRGLPGLREPAAFYGWVRSVTVREAVRTARRLGRETTSPEVDSRHEPHSLDAVHINDVLDRMSEAHRQVLTLRVYGLNEVEMAETLALPVGTVRSRLHRARRRFQEAWQPTAA	MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWEGQLRISAVNQVEFLESLFLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMDIDNENKLPLRKSIPTKIMASEGIIGG	65.28	gnl|BL_ORD_ID|266|hsp_num:0	295			282	522	cloxacillin; oxacillin; cefalotin
BGC0001216.1|Splenocin_2 # 580 # 1881 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.727	BGC0001216.1|Splenocin_2 	580	1881	-	Loose	600	26.1794	clbA	27.91	3002814	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGCGACGCGCGCTGTGTCCCGTGGAAAACCTCTATGTAGCCCAGCGGAGCAGGGCGTTCCTGTCCTGTGCCCTGCGCGGGGACATCGACTCCTCGGCGCTGGCGAGCGCTTTCGACGCCCTCACGACGGAGCACCCCACCCTCCGCTCCCGCATCGTCCCCGCAGAAGGGGGCCACGCCCTGGAACTCCTCCCGGAGGACGAGCGCCCGCGCCTGATCCTCAAGGAGGGCGGGGACGAGGCGTACATCGAGGAACTGAACGTCCCGCTTCCGGTGGGCGGACCGCTCAGCCGCGCGGCCCTGGTCACCACCGGGCCGGAAACCCGCCTCCTGACCGTGACGATCGACCACACCGTCACCGACGGACACAGCGCCATCACCCTCATGAACGCGCTCTGGGACCGCTACAGCGATCTCGTCGGGACCGTCCCGGCGCAGACTCCGCCCGTCCCCGTCGCCGAGGGGGACTGGCCCAGGCCCGTCAGTGAGCTGCTGCCCCCGGCCGACGCCGAGGACACCGAGAAGTACCTCCGGCGCCGCATCGAGGAGACGAGCGCCCACCCGGTCGAGCTCCTCGCCTACGACACCCCCCGCGACCGGCCCGCCGACCCGTCGGAGCACCGCATCGAGGTCCGCCGCCTGGTCCTCGGCGCCGAGGAGACCACCCGGCTGCGCTCCGCCGCCCGCGACGCGGGCGTCTCGGTGCACGGCCTGGTCGCCGCCGCCCTGATGACGGCTGCCCGCGCGCGCCTGGACGGCGACGGTCCGCGGACCCTGGGCTGCATGTCGCCCGTCGACCTGCGTGCGCGGCTCACCCCGCCCGTCTCACCGTCCGTGATGGTGGCCTCCGTGACCTCCCACCTCCAGGCCGTCCCGGTCGGTGGGGAGACCGACCCGCTGGACCTCGCCCGGAAGATCAGCAGCCGCCTGCGGGAGTCCGTCGAGCGCGGCGACCACTTCCACGAGATGCGCATCATGCCGAGGGTCCCGGCCCACCCCACCCTGCAGATGGGCTCGGTCATCGTGACCAACATGGGCGCCACGGCCGCCCCCCGCTTCCCCGAGGGCCTCGAAGCCACCGACGTCCGCCTCGTCCCGGCTCGCGAGTCGTACTTCCCCCAGGCCGGCCGCAGCCCGGTCATGGCCTGCGTCGTCTCCTTCGACAACCAGCTCGCCGTCGAACTCCCGCACCACACGGCCTGCTTCACCCCGCAGTACATGCGGGCCTTCCGCGACGACGTCCGCACCGCGCTGCTGGCCTTCACCGAGGACACAGCCCCGGCACCGGTCACCGCCGGCTGA	MRRALCPVENLYVAQRSRAFLSCALRGDIDSSALASAFDALTTEHPTLRSRIVPAEGGHALELLPEDERPRLILKEGGDEAYIEELNVPLPVGGPLSRAALVTTGPETRLLTVTIDHTVTDGHSAITLMNALWDRYSDLVGTVPAQTPPVPVAEGDWPRPVSELLPPADAEDTEKYLRRRIEETSAHPVELLAYDTPRDRPADPSEHRIEVRRLVLGAEETTRLRSAARDAGVSVHGLVAAALMTAARARLDGDGPRTLGCMSPVDLRARLTPPVSPSVMVASVTSHLQAVPVGGETDPLDLARKISSRLRESVERGDHFHEMRIMPRVPAHPTLQMGSVIVTNMGATAAPRFPEGLEATDVRLVPARESYFPQAGRSPVMACVVSFDNQLAVELPHHTACFTPQYMRAFRDDVRTALLAFTEDTAPAPVTAG	MQQKNKYIRIQEFLKQNKFPDFRMNQIKNAVFQGRINHFNEITVLPKSLRKLLIEEFGESILNIAPLKVQHSEQVTKVLFEISGDEKIETVNMKYKAGWESFCISSQCGCHFGCKFCATGDIGLKRNLTSDEMTDQILYFHLKGHSIDSISFMGMGEALANVQVFDALHVLTNPELFALSPRRLSISTIGIIPGIKKITQDYPQVNLTFSLHSPFNEQRSKLMPINERYPLLEVMDTLDEHIRVTSRKVYIAYIMLPGVNDSIDHANEVVNLLRSRYKRGNLFHVNIIRYNPTVSSPMRFEEVNEKQVVNFYKKLKSAGINVTVRSQFGIDIDAACGQLYGNYQKNKNQ	124.07	gnl|BL_ORD_ID|519|hsp_num:0	571			723	852	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0001216.1|Splenocin_4 # 2525 # 11218 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.751	BGC0001216.1|Splenocin_4 	2525	11218	+	Loose	1000	142.124	almE	26.57	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTCTGGCAACGAGGACGATCGTCGGCCGCTTTCCGGAGCGCAGGAGGGGCTCTGGTACGCCCATCGGCTCGCGCCCGGCACCGCCGCCTACAACACCGGTGAGTACGTCGAGATCCACGGGCCCCTCGACACCGCCGTCTTCGAGACGGCGCTGCGGCGGACCGTCCGCGAGGCCGACACCTTCGCCCTGCGCTTCCTCGACACGCCCGACGGACCGCGTGCCGTGCGGGACGGCGATCCGGACGAGATGCCGGTGCACCGGGTGGACGTCAGTGGTGCGGCGGACCCGGCGGCCGCCGCCGAGGAGTGGATACGCCGGGATCTGGCGACTCCGGTGGACGTGGCGGCGGGACCGCTCTTCTCGCACGCCCTGCTGACGCTCGCCCCGGACCGGTTCATCTGGTTCCTGCGCGCCCACCACATCCTGCTGGACGGCTACAGCTACAAGCTGGTGGCGCGCCGTCTGGCCGACACCTACACGGCGCTGGCCGCCGGGGAGGAACCGCCGCCCGCCGGCTTCGAGTCCTCGGACCGCCTCGCCGCCGAGGAGGCCGCCTACCTCGGCTCCGACCGCCATCAGCGCGACCGCGCGTACTGGACGGAGCGGCTGGCGGGGCTGCCGGAGCCGGCGCGGCTCACCGACCGCACCGCGCCGCCCAGGGCTCCGTTCCTGCGCCGCACGGCGGTCCTCTCCCCCGCCGAGACGCGGGCCCTGGACGAGGCCGCCAAGGGGATGGGGGTCGCGCGGACCGATCTGCTGGTCGCCGCCGTCGCCGCCTTCCTGCACCGGATGACCGGCGCCGACGATCTGGTCCTCGGGCTCGCCACGATGAGCCGGCTGGGCAGCGCGGCGCTGCGTACCCCCGGTACGGCCTCGGACATCCTGCCGCTGCGGATCGCGGCCTCGGCGGACACGCCGGTCGGCCTGTTCGTCCGGGCGGTCGCGGACGACCTGCGCGGGCTGCGTACCCACCAGCGCTACCGCGGTGAGTCGATCCGCCGCGACCTCGGCGTGCTGGGCCGTGGCCGCCGTGTGCACGGACCGGTCGTCAACATCGTCCCCTTCAGCGAGGACCTCACCTTCGGCGGGCACCCCTCGACCTCCCACCACCTCTCGGGCGGGGCCGTCGACGACCTCCAGATCTCGGTGCGGCCCGGCGCGGAGGCGGACACCGTCTGGCTGGCCTTCGACGCCCACCCCGACCTGTACGAGGAGGACGGACTCGCCCTGTTCCTGGAGCGGTTCCTCAAGGTCCTGCGCGAACTGCGGACCGCCCCCGAGGAGCTGCCGCTGGGTGAGACTCCCGTGCTGCTGCCCGGCGAGGAGCCCGTCCGCCGGGACGAGCCCGCACCCCGCGTGACGCGCACCCTCCCCCAGCTCTTCGAGGCCCGCGTCGCCGACGGCCCCGGCCGCACCGCCGTGTCCTACGCCGGGGAGACGCTGAGCTACGCGGAACTGAACGCGGAGGCCAACCGGCTGGCCCGGCTGCTCGTCGAGCGGGGGGCGGGACCCGGCCGGTTCGTCGCCCTGGCCCTGCCCCGGGGCCTGCCGCTCGTCGCCGCGCTGCTCGCCGTCCTCAAGACGGGCGCCGCGTACCTTCCGCTGGACCCCGGGCACCCCGCCGAGCGGCTGAGGCTGGTCATGGCGGACGCGGAGCCCGTCGCCGTCGTCACCGACACCGCCGGATCGGGACGGCTGCCCGCGACGGACGCGCAGGTCGTGGTGGTCGACGACACGGAGACCATGGCAGACCTGGCGGGCCGCGCGCCGCACGACCTGACGGACGCGGACCGCGCGGGCGCGACCGACCCCTACGACACCGCCTACGTCATCCACACCTCCGGCTCGACGGGGCGCCCCAAGGGCGTGCCGGTGCCGCACGCCCACGTGGTGCGGCTCTTCGAGGCGTCCGGGGAGCACTTCCGTTTCGGCGCGGACGACGTGTGGACGCTGTTCCACTCGTACGCCTTCGACTTCTCGGTGTGGGAGCTGTGGGGCCCGCTGCTGCACGGCGGGCGGCTGGTCGTGGTGCCCTACGAGGTGAGCCGTTCGCCCCGGGAGTTCCTGCGGCTGCTCGACGAGGAGGGGGTGACGGTCCTCAACCAGACGCCGTCCGCCTTCGAGCAGCTGGTCCTGGCGGACGCCGAGACGGACCGTTCCGCGGGCTCCCTGCGGTACGTGGTCCTCGGCGGGGAGCCGCTCGTGGCGGAGCGGCTGCGCCCGTGGGCCGGCCGGCACGGCCTGGACGCGCCGGAGCTGGTCAACATGTACGGCATCACCGAGACGACGGTGCACGTGACCTTCCACCGGCTGGTCCGTGCCGACCTGGAGGACCCGCGCCGCCGCGGCGTCATCGGCCGGCCCCTGGCCGACCTGCGGGTGTACGTCCTGGACACGGACGGCCGGCCGGTGCCGCCCGGGGCGACCGGCGAGATGTACGTGTCCGGGCCGGGGGTGGCGCCCGGTTACCTGAACCGGCCGGAGCTGACGGAGGAGCGGTTCCTGCCGGACCCCTACGGAACGCCGGGCACCCGGATGTACCGTTCCGGCGACCTGGCCCGGTGGCGGCCCGACGGCACCCTCGTCCACGCGGGCCGCGCCGACCAGCAGGTCAAGATCCGCGGCTTCCGTATCGAGCCGGGCGAGATCGAGGCCGTGCTCACCGCCCACCCGGCGGTCGCCGGCGGCGCGGTCGTCCCACGCACCGCTGAGGACGGCCTGACCCAGCTCGTCGCCTACGCGGTGCCCGCCGGGGAGGGCCCGGCTGACCCCGCCGGGTTGCGGGCCCACCTGGCGGCGCGGCTGCCCGCCTACATGGTCCCCGCAGCCTGCGTGCTCGTCGACGCGCTTCCCCTGACCGCCAACGGCAAGCTCGACACGGCGGCCCTGCCCGCCCCCGACTTCGGCGGCGTCACGGACGGTGCCCCGCCCACGACGCCCGAGGAGCGCCTGGTGTGCGGCCTGTTCGAGGAGGTGCTGCGGCTGCCCGCGGACTCCGTCGGCACCGGCGGCAACTTCTTCGACCTCGGCGGCCACTCGCTGCTCGCGACCCGGCTGCTGGCCCGGCTGAGGGAACGGACCGGCACGGACGTCCCGATCTCGGCGCTCTTCGACACGCCGACCCCGGCGGCCCTGGCCGAACGCCTCGCCGCCGGACCGGACGCCGGCCGGCCGCTGCCCGCGCTGACGGCGTCCGAGCGCCCGTCCCTGGTGCCCGCCTCCTTCGCCCAGGAACGCATGTGGTTCCTCAGCCGCATGGACGGCGCGGCGGCCACCTACAACATTCCCCTGCCCGTCCCCCTGCGGCATCCACTGGACCTGGACGCGCTGCGCGCCGCCCTGGGAGACGTCGCCGACCGCCACGAGAGCCTGCGCACCGTCTTCGGGGAGGAGAACGGTGCGATCCACCAGCGGGTCCTGCCACCCGGCACGCTCCGGCCCGAACTGCACGTGGTGGACTGCCCCGACGAGGAACGCGCCGCGCACGTGGCCGCGGCGATGGGGCGCTCCTTCGACCTGACGCGTGACAGCGCGCTGTGGGCGGGGGTGTTCGGTACCGGTGACACGCGCACCCTGCTGCTCGTGCTGCACCACAGCGCGGCCGACGGCTGGTCGCTGCGCCCGCTCGCCGACGACCTCGGCACCGCCTACGCCGCGCGCCGCGCGGGTGCGGCGCCTGACTGGGTGCCGCCGGCCCTTCAGTACGCCGACTTCGCGCTCTGGCAGCGGCGGGTGCTCGCGCCCGCCCCGGAGGGGCCGGGGCGGCTGGAGCGGCTGACCTCGTTCTGGCGCCAGGCGCTGGGCGGGCTGCCCGAGGAGAGTGCGCCGCCCCCGGACCGCCCCCGGCCGGCGGCCCCATCCGGGCGCGGTGGCGGCGTGACCGTGCCCCTGGACGCCGGGACGCACCGGGAGCTGCTGCGCCTGGCGGACCACGAGAACGCCAGCCTCTTCATGGTGCTGCACGGTGCGCTGGCCCTGCTGCTGAACCGGTGGGGCGCAGGTGAGGACATCGTCGTCGGCACCCCTGTGGCCGGACGTTCCGAGCCCGCACTCGACGAGGTCGTCGGGCTGTTGACCAACACCCTCGTGCTGCGCGCGGACGCCTCGGGCGACCCCACCTTCCGCGAACTCCTCGCCCGCGTGAGGGCGTTCGACGTGCAGGCGCTGGACCACCAGGATCTGCCGTTCGACCGGCTGGTCGACGAGATGAACCCGCGCCGCCACCCTGCCCGGCATCCGCTGTTCCAGGTGATGCTGGCCCTGCAGAACAACGAGCGGGCCGTGCTCACGCTCGGCGAGAACCGGGTGCCGCTACGCCCGGCCGCGACCGGCACCGCCAAGTTCGACCTCTTCGTCGACGTCCTGGAGCGGCACGACGCGGACGGCACCGCCGACGGGCTCGACCTGCACGTCGAGTACGCGGCCGACCTCTACGCCCCGGCCACCGCCGAGAGGTTCGCGGGCGCGCTGCGCGACCTGCTGGCCATGGTCTGCGCCGACCCCGAGGTGCGGCCCGGCGCCCTGCCGCGTGCGGAGCGCCCCTCCCCTGCCGCCGCGGACACCACCGCCCTGGCCGGGGCGCTGGCCCGCTCCGTCCTGGAGGTGCCCGGGGTGGGGGACGCGGTCGTCCTGCCTGGTCCGGACGGGGAGCCCGCCACGGTGTACGTGGTGCCGAACCGGACCGGCGCCGTCGACCGGACCGAGCAGGTGGTCTCCTCCGTCGCGCCGGGAACACGGGTCGTCGCGGTCAGTGGACTGCCCCGTACGGCCGAGGGTTCCCTGGACGACGGCGCGTTGAGGGACCTTCCCGTCGTCGACGCGGTGGCGGCGGGTGCCTGGCGGGAGCGACTCGCCCACCTGCCGGGCGTCCGCGAGGCCGAGGTGGTCCTGGAGGAGGTGCCCGAGGAGCTGGGGCGCCGCCACGCGGGACGCCCCCGGCCCGTCGGGGCGGAGGCCGGGCAGGACGCGCCGTCCGTCAGGCGTCCGGCGGCCGTCCCCGCGCTCAGCGAGGGCCCCGCGCTGCCCGAGCCGTCGGTCTCCGGCTGGGCCGAGGCGCTGCTCCGCGCCGCGGACCGCCCGGACGGCGAGGTCGTGCACGTGCGCGCGGACGGCTCGGAGACCCGGCGTTCGTACGCGAGTCTCATCCCCGAGGCCTCACGTGTCCTGGCGGGCCTGCGCCGACGGGGCCTCAGGCCGGGTGACCGGGTCATCCTCCAGTGCGAGGACACCGAGGACTTCGTCGCCACGCTGTGGGGCTGCGTCCTCGGCGGCTTCGTCGCCGTCCCGCTGACGGTGCCCGTCTCGTACGCCACCACCTCGGCCGCCGTCAGCAAGCTCGAAGGCATCTGGGAGATGCTGGACCGGCCCTGGATCGTGACCTCGGCCGCCGGTGAGCCGGGGCTGCGGGAGCTGGCCGCCCGGCGCGAGTGGTCCGGGCTCCGGCTCACCACGGCCGACGCGCTGCGCGAGGAGCCCGAGGACCGCGACTGGTACGAGGCCCGGCCCGACGACCTGGTCCTGATGCTGATGACCTCGGGCAGCACCGGTCTGCCGAAGGCGGTGCGGCTCACCCACCGCAACGTACTGACCCGAGCCGCGGCCACCGAGGCGATGAACGGGCTGGGCTCCGGTGACGTCTCCCTGAACTGGATCCCGCTCGACCACGTGACCGGCGTGGTCATGTTCCACCTGCGCGACGTCTACCTCGGCTGCCGGCAGATCCACGCGCCGACCTCCTGGATCCTGGAGGACCCGGTGCGATGGCCGGAACTGGCCGACCGCCATCGCGTGAGCGTCACCTGGGCCCCGAACTTCGCCTTCGGGCTCCTCGCCGAGCAGGCCCGACGCTTCCACGACCGCGACTGGGACCTCTCTCCCATGCGGCTGGTGATGAACGCCGGCGAGGTGGTCGTGGCCTCCGCGGCACGACGGTTCCTGCACGTCCTCGCGCCGTTCGGCATGCCCCAGGACGTCATGCACCCGGGCTGGGGCATGTCGGAGACCTGCTCGGTGGTGACCGACAGCGTGCTGGCCTCCGAGGCGCCGGACCACGACGAGGCGTTCGTCAGCTGCGGCCTGCCCTATCCCGGATTCGCCATGCGCGTCGTCGACGACCAGGACGCGCTCCTGTCGGAGGGCGAGGTGGGCCGGCTCCAGGTCCGCGGCACCTCGGTGACACGCGGCTACCACGACAACGAGCGGGCCAACGCCGAGTCGTTCACCGAGGACGGCTGGTTCGACACCGGCGACCTGGCGTTCCTGCGCGAGGGCGAGCTGTACATCACCGGGCGCGCCAAGGACGTCATCATCGTCAACGGCGTCAACCACTACAGCCACGAGATCGAGGCCTGCGTCGAGGAACTGCCCAGCGTCGTGCGGAGCTTCACGGCCGCGGTCGCCGTCCGGTCCGACGCGTCGGCATCCACCGACGAACTGGCGCTCTTCCTCCGTCTGGCCCCCGGCCAGGACCCGGCCGGTGCGCTCCGTGAGATCGCCGGCAAGGTCACCCGGGAGATCGGGGTGAGCCCCGCGTTCCTGATCCCCGTCGAGGCCGACACCATCCCGAAGACGGAGATCGGCAAGATCCAGCGGACCAAGCTGCGCAAGTCCTTCGAGGCGGGCGACTTCGACGGCGCCGTCCGCGAGACGCAGCTGTTGCTCGGCACGGCCGCCACCCTGCCTGACTGGTTCCTGCACCCGGTGTGGCGGCGCGCCGAGAACCTGCACGGGGCCACTCTTCCGACGGGCCACCGCGTCCTCGTCCTCGCCAGTCCCGCGCCTCACGCCCACGCGGTGGCCGGGGAGATCGCCGCGGCGGTGCGCGACGCCGACGGACTGTGCACGGTCGTCACTCAGGGCCCGGCCCCCGAGCGGAACGGCGCGGCCGCCTACCGCGTACGTCCCGGCGAGGCCGGGGACCTCGCGGCGGTGCTGGAGAGGCTGGACGCGGACGGGCGTACGCCGGACACCGTGGTGCACCTCGCCGCGGCGGCCGGCGCGGAAGACGGCGCGGCCCCCGGAAGCGACGTGTCGCTGCTGCTGCTGGCACAGGCACTCGCCGGCCGGACCGGCGGCGACCGGCCGGTGGACCTGCTGTTCGTGACCGCCGGCGCCCAGGCCGTGACGCCCGAGGACCGGCCCACGCTCTCGCACGCCGCGGCCGGGGCACTGCTCAAGTCGCTGCGCGAGGAGCTGCCGTGGCTGCGCGGCGTCCACCTCGACCTCTCCGGCGGGGGCGCCGGGGACCAGGCGGCGGCAGTGCTGGCGGAGGCGGCCGGGTTCCCGGCCGACACCGAGGTCGCCCGGCGCGACGGCCTGAGGTACGTGCGGCGGCTGGTCCCGCTGCCCGACCCGGCGCCCCGGACCGCACCCGTCCCGGCCGACGGCTTCCACCTGGTCAGCGGTGGTCTCGGCGGCGTCGGCAGCGAGGTGGCCGCACACCTGCTGAAGGAGCCCGGCACACGGCTGCTGCTCATCGGCCGCACCGGGCTGCCCCCCGAGGACACCTGGCAGCGGCACCTGGCGGACGCGGGGCCCGCCTCGGCCCGTATCGAGGCGTTCCGCCGGCTGCGACGGCTCGGCGAGGTCCGTTACGAGACCGCCGACGTCACCGACGCCGCGCAGGTGCGGGCGGCCGTGCGGCGGGCCGCCGACGCCTGGGGCGTCCCGCTGGTGTCGGTGCTGCACCTGGCCGGCGCCCTCGACGAGCGGCCGGTGCGGGAACTCACCCCGCAGGACTGGCGTGAGGCGCTCGCGGCCAAGGTCGACGGGGCGTGGACCCTGCACCGGGTCGCCGCCGACCACCCGGTCGCCTCGTTCGTCACCTTCTCCTCCGTCAACGGGTTCTTCGGCGGCGCGATGAACGCGGCCTACTCGGCGGCCAACGCGGCGCTGGACGACCTCGCCGTCCGGCGCCGGCGCGAGGGCCTGCCGGGACAGAGCCTCGCCTGGAGCATGTGGCGCGAGCGGGGGATGAGCCTCGGCTACCAGCTCACCTCGCTCACCGAGGCGCGCGGCTACCGGGTGCTGGACACCCAGGCGGCACTGCGCTCCTTCGACCTCGCGCGCACGCTGGACCTCCCGCACCTGCTCATCGGCGCCGACCGCACCGCCCCCTGGGTGCGCTCGCACGTCCTCGCACCGGTACGGCAGGTACGGCGCACGGCCGCCCGGGTCGTCCTCGACGAGGGCACCGATCTGGGCGCCCTGTACCGCGCGGCCGCGCGGGCGGCCGGACCGGAGGGCACGTTCGTCCTGCGGTCGGCCGGCTCCGCCGACCGGAGCGAGGACACCGGCGGCGCCGACGAGATGCGCCGGCTGGAGGGCGAGCTGGCCGCGGTGTGGTGCACGGTCCTGGGCCGCGACCGGGTGGGGCGGGACGAGAACTTCTTCGACCTGGGCGGCAACTCACTGCTGCTCGTGGCGGCGCAGACCGCGGTCAACAAGACCCTCGGGTGCGATCTGGGCGTCGTGGACCTCTTCTCCCGTCCCACCGTGCGGGCCCTCGCCCGGCACCTGTCCCAGCAGGGGGCGGCGGCCGCGCCACGGCACGCCGCGTCCGGGCCGGTCTCGGACGACCCCGCTCCCCCGCCCTCCGGGCTGGAGCGGGCCAAGCAGCAGGCAGAGCGGCAACGGGCGGCGCGGAGCGCCCGCCGGTCCGCGCAGCAGAGGAAGGACCGACGCCATGGATGA	MSGNEDDRRPLSGAQEGLWYAHRLAPGTAAYNTGEYVEIHGPLDTAVFETALRRTVREADTFALRFLDTPDGPRAVRDGDPDEMPVHRVDVSGAADPAAAAEEWIRRDLATPVDVAAGPLFSHALLTLAPDRFIWFLRAHHILLDGYSYKLVARRLADTYTALAAGEEPPPAGFESSDRLAAEEAAYLGSDRHQRDRAYWTERLAGLPEPARLTDRTAPPRAPFLRRTAVLSPAETRALDEAAKGMGVARTDLLVAAVAAFLHRMTGADDLVLGLATMSRLGSAALRTPGTASDILPLRIAASADTPVGLFVRAVADDLRGLRTHQRYRGESIRRDLGVLGRGRRVHGPVVNIVPFSEDLTFGGHPSTSHHLSGGAVDDLQISVRPGAEADTVWLAFDAHPDLYEEDGLALFLERFLKVLRELRTAPEELPLGETPVLLPGEEPVRRDEPAPRVTRTLPQLFEARVADGPGRTAVSYAGETLSYAELNAEANRLARLLVERGAGPGRFVALALPRGLPLVAALLAVLKTGAAYLPLDPGHPAERLRLVMADAEPVAVVTDTAGSGRLPATDAQVVVVDDTETMADLAGRAPHDLTDADRAGATDPYDTAYVIHTSGSTGRPKGVPVPHAHVVRLFEASGEHFRFGADDVWTLFHSYAFDFSVWELWGPLLHGGRLVVVPYEVSRSPREFLRLLDEEGVTVLNQTPSAFEQLVLADAETDRSAGSLRYVVLGGEPLVAERLRPWAGRHGLDAPELVNMYGITETTVHVTFHRLVRADLEDPRRRGVIGRPLADLRVYVLDTDGRPVPPGATGEMYVSGPGVAPGYLNRPELTEERFLPDPYGTPGTRMYRSGDLARWRPDGTLVHAGRADQQVKIRGFRIEPGEIEAVLTAHPAVAGGAVVPRTAEDGLTQLVAYAVPAGEGPADPAGLRAHLAARLPAYMVPAACVLVDALPLTANGKLDTAALPAPDFGGVTDGAPPTTPEERLVCGLFEEVLRLPADSVGTGGNFFDLGGHSLLATRLLARLRERTGTDVPISALFDTPTPAALAERLAAGPDAGRPLPALTASERPSLVPASFAQERMWFLSRMDGAAATYNIPLPVPLRHPLDLDALRAALGDVADRHESLRTVFGEENGAIHQRVLPPGTLRPELHVVDCPDEERAAHVAAAMGRSFDLTRDSALWAGVFGTGDTRTLLLVLHHSAADGWSLRPLADDLGTAYAARRAGAAPDWVPPALQYADFALWQRRVLAPAPEGPGRLERLTSFWRQALGGLPEESAPPPDRPRPAAPSGRGGGVTVPLDAGTHRELLRLADHENASLFMVLHGALALLLNRWGAGEDIVVGTPVAGRSEPALDEVVGLLTNTLVLRADASGDPTFRELLARVRAFDVQALDHQDLPFDRLVDEMNPRRHPARHPLFQVMLALQNNERAVLTLGENRVPLRPAATGTAKFDLFVDVLERHDADGTADGLDLHVEYAADLYAPATAERFAGALRDLLAMVCADPEVRPGALPRAERPSPAAADTTALAGALARSVLEVPGVGDAVVLPGPDGEPATVYVVPNRTGAVDRTEQVVSSVAPGTRVVAVSGLPRTAEGSLDDGALRDLPVVDAVAAGAWRERLAHLPGVREAEVVLEEVPEELGRRHAGRPRPVGAEAGQDAPSVRRPAAVPALSEGPALPEPSVSGWAEALLRAADRPDGEVVHVRADGSETRRSYASLIPEASRVLAGLRRRGLRPGDRVILQCEDTEDFVATLWGCVLGGFVAVPLTVPVSYATTSAAVSKLEGIWEMLDRPWIVTSAAGEPGLRELAARREWSGLRLTTADALREEPEDRDWYEARPDDLVLMLMTSGSTGLPKAVRLTHRNVLTRAAATEAMNGLGSGDVSLNWIPLDHVTGVVMFHLRDVYLGCRQIHAPTSWILEDPVRWPELADRHRVSVTWAPNFAFGLLAEQARRFHDRDWDLSPMRLVMNAGEVVVASAARRFLHVLAPFGMPQDVMHPGWGMSETCSVVTDSVLASEAPDHDEAFVSCGLPYPGFAMRVVDDQDALLSEGEVGRLQVRGTSVTRGYHDNERANAESFTEDGWFDTGDLAFLREGELYITGRAKDVIIVNGVNHYSHEIEACVEELPSVVRSFTAAVAVRSDASASTDELALFLRLAPGQDPAGALREIAGKVTREIGVSPAFLIPVEADTIPKTEIGKIQRTKLRKSFEAGDFDGAVRETQLLLGTAATLPDWFLHPVWRRAENLHGATLPTGHRVLVLASPAPHAHAVAGEIAAAVRDADGLCTVVTQGPAPERNGAAAYRVRPGEAGDLAAVLERLDADGRTPDTVVHLAAAAGAEDGAAPGSDVSLLLLAQALAGRTGGDRPVDLLFVTAGAQAVTPEDRPTLSHAAAGALLKSLREELPWLRGVHLDLSGGGAGDQAAAVLAEAAGFPADTEVARRDGLRYVRRLVPLPDPAPRTAPVPADGFHLVSGGLGGVGSEVAAHLLKEPGTRLLLIGRTGLPPEDTWQRHLADAGPASARIEAFRRLRRLGEVRYETADVTDAAQVRAAVRRAADAWGVPLVSVLHLAGALDERPVRELTPQDWREALAAKVDGAWTLHRVAADHPVASFVTFSSVNGFFGGAMNAAYSAANAALDDLAVRRRREGLPGQSLAWSMWRERGMSLGYQLTSLTEARGYRVLDTQAALRSFDLARTLDLPHLLIGADRTAPWVRSHVLAPVRQVRRTAARVVLDEGTDLGALYRAAARAAGPEGTFVLRSAGSADRSEDTGGADEMRRLEGELAAVWCTVLGRDRVGRDENFFDLGGNSLLLVAAQTAVNKTLGCDLGVVDLFSRPTVRALARHLSQQGAAAAPRHAASGPVSDDPAPPPSGLERAKQQAERQRAARSARRSAQQRKDRRHG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	521.04	gnl|BL_ORD_ID|4935|hsp_num:0	5928			159	1629	colistin A; colistin B
BGC0001216.1|Splenocin_5 # 11211 # 15032 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=12bp;gc_cont=0.755	BGC0001216.1|Splenocin_5 	11211	15032	+	Loose	790	29.6462	mtrC	25.0	3000810	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATGACCCGCAGGCCCTGCCGGAGGACGAGGCGCCCGCCGTCGCCGTGATCGGCATGGCGGCGCGCTTCCCCGGCGCCGACGACGTCGACGCGTTCTGGGACAATCTCGCCAGGGGGCACGAGTCCGTACGGCCGGTCAGCGACGAGGAGTTCCTCGCGGCCGGCGGTGACCCGGAGGACCTCGACGACCCGTCCCTGATCCGGATGGCGTCGGTGATCGAGGGCATCGACCGCTTCGACTCGGGCTTCTTCGGGTACAGCCCGGCCGAGGCGGCGGTCGTCGATCCGCAGCAGCGGTTGCTGCTGGAGACGGCCTACCACGCGCTGGAGGACGCGGGGCACCTCGGCGAGGACACCCCGTCCGGCACGACCGGGGTGTACGCGGGCAGCGGCGACAGCCGCTACTACCCCGCGCACGTGCACCCCCGGTTCGCCGGGCAGCCCGGCTCGGTGGCCCTGGTCCACGCGGCCACCGCCAACTCGCTGGGCACGCTCGCCACCCGGGTCTCCTACGAGCTGGGCCTGACCGGGCCGAGCCTGTCGCTCCAGACCGCCTGCTCCACCGGGCTGGTCGCGCTGCACACCGCCTTCCAGGATCTCGTCGAGTACCGCTGCGACACGGCACTGGCGGCGGCGGTCTCGCTGAATCCCTCGGCCCACCTCGGCTACCGCCACGTGCCCGACGGCCCGTTCTCCCCCGACGGGCACTGCCGTACCTTCGCCGACGACGCGGCGGGCACCTCGTCCGGCGACGGCGTGGGCGCGGTGGTCCTCAAGCGGCTGGAGGACGCACTGACCGACGGGGACCGCATCCGGGCCGTCGTCCGCGCCACGGCCGTCAACAACGACGGCCGACGCAAGGTCGGCTTCACCGCGCCGAGCACGCAGGGCCAGACGGAGGTGGTGCTCGCCGCGCAGGCGCAGGCCGGGATCGACGCGGACACCATCGGTCTGGTCGAGGCGCACGGCACCGCCACCCGCATCGGCGACCCCATCGAGGTGGCGGCGCTCACCGAGGCGTTCCGCCAGAGCACCGACCGGCGCGGCTACTGCGCCCTCGGCTCGGTCAAGACCAACATCGGGCACCTGGGCGCGGCGGCGGGAATGGCCGGGCTCGTCAAGGCGGTGCTCGCGCTGGAGCACCGCCGGATCCCGCCGAGCCTGCACTTCGACCGGCCGAACCCGCTGATCGACTTCGCCTCCGGCCCGTTCCGCGTGCCGACCACGCTGGAGGAGTGGCCGCAGGAGGCCGGTCATCCCCGGCGTGCCGCGGTCAGCGCCTTCGGGGTCGGCGGCACCAACGCGCACGTGATCCTGGAGGAGGCTCCACCGGTCGCACCGGCCCCGCCGCGCCCCTCGGAGGAGGGCCGCCGGCTCGTCCTGCCGGTGTCGGCGCGGACCTCGGGGGCGTTGCGGGGGCAGGCCCACGCCCTAGCGCGCCGGCTGGAGGAGCGGCCCGGGCTCCGGCTGGACGACGTGGCGGGCGCGCTGCGCGCCGACCGGCCCGCCCTGCGGCACCGTCTCACCGTGTCGGCTTCTTCGGTGCCGGAGGCGGTGGAAGCACTGCGCGCGGCGGTGCCCGCCGTGCCGCCGGTGCCCGACGAGCCGCCGAAGGTGGCGTTCCTGCTGCCGGGCGGCGGCACCCAGTACGTCGGCATGGGCAGTGGGCTGTACCGGGAGAACGACGTGTACCGGGACACCGTGGACCGGTGTGCCGCGGTCCTGCGGCCGGCACTCGGCTCGGACCTGCGCACCGCCCTGTTCGAGGAGGTGGAGCCGGGCAGCACGGCCGCCTTCATGGCGCTGTTCGTCACCGAGTACGCGCTGGCCCGCACCCTGATGGAGGAGGGGGTCCGGCCCGACGCCCTGATCGGGCACTCGCTGGGCGAGTACACCGCCGCCTGTCTGGCCGGGGTGATGGAGATCGACGAGGCGCTGCCGGTGGTGGCCGAGCGCATCCGGCTCATCGCCTCCTCGGGCGGAGCCACCGTCGGCGTCGCGGCCTGTGCCGACACCGTCCTCCCGCTGCTGGGCGAGGGGCTGTCGCTGGCGGCGGTCAACAGCCCGGTGGCGTGCACGGTCGCCGGCGACACCGACGCGGTCGACCGGCTGGAGGCGGAACTGACCCGCCGCGGCGTGCCGTTCCGCCGCCTGCGCATGCCCGCCGCCGCCCACTCGCACGTGCTCGACCCGATCCTGGAGAGCTTCGCCGGTCACCTGCGCACGCTGACACTACGGCCGCCTCGCATTCCCTACGTCACGAACGTGACGGGCGACTGGGCCACTGACGCGCAGGCGACGGATGTCGGTCACTGGGTGGACCACACCCGGCGCACCGTCCGGTTCGCCGACGGCATCGCGGCGCTGTGGGAACGGGAGCGGCCGGTCCTCGTCGAGATCGGCCCCGGCGACAGCCTCACCAAGCTGGCGCGGGCGCGGCTCGACGGCGAGGGCCCGGTGACCGTGACGACCATGCGGCACGCCAAGGCGCAGGCGGCGGACGGCTTCGTACTGGCCGAGGCGCTGGGGCGGCTGTGGAGCGCCGGTGTGGACGCCGCGCTCCCGCACGTCCCGCGGCCGCCGCGCGGCGCGGGGCGGGTGCCGCTGCCCGGGTACGCCTTCGAGCGCCACCGCCACTGGATCGACGCACCCGGGGCGCGCGCCCCGGAGGAGTCCGGCACCCGGCCCAAGACGCCGGCCCCGGGCGGGGGCACCGGGCTCGCGCCGCGTCCGCACCTGGCGACCGCCCACGTGGCTCCCAGCACCCCGCGCGAGCGGGCGGTGGCCGAACTGTGGGAGGAGTCCCTCGGGATCGGTGGCATCGGGGTCCACGACAACTTCTTCGACCTGGGCGGCGACTCGATGCGCGCCGTGCTCCTGGTGGGGCGGCTGCGGCAGAAGGGTGTGCTGGACGTGCCGGCCGCCTCCCTGCTGGCCGCTCCGACGGTGGCGGGCCTGCTCGCCGCCGGCGAGCCCGCCGAGGGCGCCGTCGCCGGGCCGGGCGCGCTGGCGCCGCTGCTGCCCCTGCGTGCCGAGGGCGGCCGGCGGCCCCTGTTCTGCGTGCACCCGGGCGCCGGAGTCTCCTGGCGGTACTCCGGGCTGCTGCCACATCTCGGCGCGGACCAGCCGGTGTTCGGCCTCCAGGCCGCCGGTCTGGACGGCACCGGGCAGCCGGCCCGCGACGCCCGGGAGATGGTCGAGGGCTATCTCGACCTCGTCCGCACGGTCCAGCCGAGCGGCCCGTACCGGCTCCTGGGCTGGTCGTACGGCGGTTTCGTCGCCCACGCGATGGCGTGCGCCCTGCAGGAGCGGGGTGAGGAGGTCGAGTTGCTGGCGCTGCTCGACGCGCCGCTCCCGCACGGGAGCGCGCACAACCCGAGCACCGCGGAGAGGCAGGTCGCGGGCCTGCTGTCGCGGGTGGCGGGGCTGCCGGCCGACGAGGCCGGCCCGCCCGGTGTCGAGGACGTGCTCGACCGGGTCGGTGAGGCCCACGCCGCCGGCTCCTCACCCGTCTCCCGCGACGAGGCGGCCTCCATCGCCGCCGTGATGCGCAACAACCTTCGGATCGCACCGGAGTTCACGCCCGGTGTCTTCCGCGGCGACGCGTTGTTCTTCAGCGCCACGCGGGACCTGGTCCCGGCCGCCGATGCCCGAGACCTGTCGCTCGCGGCCGGCAAGGCCGACGCCTGGCGCCCGTACGTACGGGGCGCCTTCGAGGACCACGCCGTGCCCTGCGGCCACTACGACATGACCGAACCCGACCCGATCGCCCGCATCGGCGAGGTCGTCGCCAAGGCCCTCCGCCCGGCCTCCGGCTGA	MDDPQALPEDEAPAVAVIGMAARFPGADDVDAFWDNLARGHESVRPVSDEEFLAAGGDPEDLDDPSLIRMASVIEGIDRFDSGFFGYSPAEAAVVDPQQRLLLETAYHALEDAGHLGEDTPSGTTGVYAGSGDSRYYPAHVHPRFAGQPGSVALVHAATANSLGTLATRVSYELGLTGPSLSLQTACSTGLVALHTAFQDLVEYRCDTALAAAVSLNPSAHLGYRHVPDGPFSPDGHCRTFADDAAGTSSGDGVGAVVLKRLEDALTDGDRIRAVVRATAVNNDGRRKVGFTAPSTQGQTEVVLAAQAQAGIDADTIGLVEAHGTATRIGDPIEVAALTEAFRQSTDRRGYCALGSVKTNIGHLGAAAGMAGLVKAVLALEHRRIPPSLHFDRPNPLIDFASGPFRVPTTLEEWPQEAGHPRRAAVSAFGVGGTNAHVILEEAPPVAPAPPRPSEEGRRLVLPVSARTSGALRGQAHALARRLEERPGLRLDDVAGALRADRPALRHRLTVSASSVPEAVEALRAAVPAVPPVPDEPPKVAFLLPGGGTQYVGMGSGLYRENDVYRDTVDRCAAVLRPALGSDLRTALFEEVEPGSTAAFMALFVTEYALARTLMEEGVRPDALIGHSLGEYTAACLAGVMEIDEALPVVAERIRLIASSGGATVGVAACADTVLPLLGEGLSLAAVNSPVACTVAGDTDAVDRLEAELTRRGVPFRRLRMPAAAHSHVLDPILESFAGHLRTLTLRPPRIPYVTNVTGDWATDAQATDVGHWVDHTRRTVRFADGIAALWERERPVLVEIGPGDSLTKLARARLDGEGPVTVTTMRHAKAQAADGFVLAEALGRLWSAGVDAALPHVPRPPRGAGRVPLPGYAFERHRHWIDAPGARAPEESGTRPKTPAPGGGTGLAPRPHLATAHVAPSTPRERAVAELWEESLGIGGIGVHDNFFDLGGDSMRAVLLVGRLRQKGVLDVPAASLLAAPTVAGLLAAGEPAEGAVAGPGALAPLLPLRAEGGRRPLFCVHPGAGVSWRYSGLLPHLGADQPVFGLQAAGLDGTGQPARDAREMVEGYLDLVRTVQPSGPYRLLGWSYGGFVAHAMACALQERGEEVELLALLDAPLPHGSAHNPSTAERQVAGLLSRVAGLPADEAGPPGVEDVLDRVGEAHAAGSSPVSRDEAASIAAVMRNNLRIAPEFTPGVFRGDALFFSATRDLVPAADARDLSLAAGKADAWRPYVRGAFEDHAVPCGHYDMTEPDPIARIGEVVAKALRPASG	MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK	308.98	gnl|BL_ORD_ID|1232|hsp_num:0	1340			768	1050	erythromycin; penicillin; azithromycin
BGC0001216.1|Splenocin_7 # 16450 # 16656 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.696	BGC0001216.1|Splenocin_7 	16450	16656	+	Loose	800	21.557	mel	46.67	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGAGCCAGACGTCGATGCGGATGAGGCTGATCGCCGCGCCGGTGAGTTGGTGCTGGAGGCTTGTCCAGGCGCGTCGCGCCCGACGGCCGGTCTTTTGGGCCACGGGGCGCCACCTCGCCATCGACCGGGTGGAAGTGCTGGACCCACACCTGCCGCAGGACCTCCAGCTCCGGCAGGGACCGCGTAGTCGAATCCCGTGTCCGTGA	MSQTSMRMRLIAAPVSWCWRLVQARRARRPVFWATGRHLAIDRVEVLDPHLPQDLQLRQGPRSRIPCP	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK	16.79	gnl|BL_ORD_ID|1130|hsp_num:0	1231			582	627	erythromycin; telithromycin
BGC0001216.1|Splenocin_8 # 16923 # 18401 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.719	BGC0001216.1|Splenocin_8 	16923	18401	-	Loose	1000	72.7886	almE	21.25	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGTGGCTGACCCAGTTGGCGGAGCGCAACCGCCAGTGCCACCCCGACCGCACCGCCCTCGTCGACGAGCGGCGTAGCGTCACCTGGGCCCAGTTCCACGACCGCACGGTCGAACTCGCCCGGGGCCTGGCCGCCCTCGGGATCCGGCGCGGTGACCGGGTCGCCGTCCTCGCCCAGGACCGGATCGAGGTGGTGGAGAGCTACTTCGCCCTCGCCCGGCTCGGCGCGCTGTTCGTGCCGCTCAACCACAGTCTGGCCGTCCCCGAGGTCGCCGGCATCATCGAGCGGGTCGGCGCCGTCGCCGTCCTCGGGGAGTCCGCCCTGCTCGACCGGCACACCTCGCTGCCCGCCTCCGTGCGCATCCGGGTGCCGCTGGACAAGCCCGTCTTCGAGGCGCTCGGCACGGTGGACGAGCCCGTCGAACTGCCCGAGGTCGCCGACACCGACCCCGTCGCGATCCTGCACACCTCCGCGACCACCGGACAGGCCAAGGGCGTCACCGTCGACGGCGGCTCCTTCCGCGCCATCGCCCTCGGCTGGCTCGTCCTGGCCCGCCCCACGGACGACATCGTGATGGTCAACTGCTGCCCGCTCTACCACGGCAGCATGGTCGTCTCCCTGACCTACATGGCCGCGGGCGCCACCATCGTGCTGATGCCCGGATTCACCCCGCAGCGCGCTCTCGCCGCGGTGGAGGAGAACCGGGCCACCCACATGTGGATGGTCCCGCAGATGGTGCGGTTCATGCTCCAGGCGAAGGGCTCCCGCAGCACCGACCTCGGCTCCCTGCGGGAGATCCTGTACGGCGCCGCGCCCATGCCGCTCGACGTGTACGCGGAGGCCGTCGAACGGCTCGGCTGCGGCTTCCGCCAGGTGTACGGCATGACCGAGGTCGGCGGTCCCTTCGTCACCCTGGGTCCGGACGAGCACCCCGAGCCCGGCGACGTCGCCGCGCGCATCCCCTGCGGACGCGTCGTCCCCGGCATGTCCGCCCGCGCCGTGGGCCAGGACGGGCAGGAGGTGCCGCGCGGCGAGATCGGCGAGATCGTCGTCCGGGGACCCGGCGTCATGCAGGGGTACTGGAACGACCCGGAGGCCACCGAGGAGGTCACGGCCGACGGCTGGGTCCTCACCGGCGATCTGGGCTTCGTCGACGAGAGCGGACGCATCCATCTGGTGGACCGCAGCAAGGACGTCATCATCCGGGCCGGGCAGAACGTCTACCCCTCGGAGATCGAACGTGCCCTGACGGCCCATCCGGACGTCCGCGACGCGGCCGTCGTCGGCGTACCCGACGAGGACTACGGCGAGGTCCCGCTCGCCTACGTCGTCGTCGAGGAGGGGACGACCACGGCCACCCTGCTCGCGCACGTCCGCGAGAACCTGGCTCCGTACAAGCGGCCCCGGTCCTTCGAGTTCATCGAGCGGGTGCCCCGCAACCCCGCCGGGAAGATCCTGAAGAAGGCGCTGCGCACCTGA	MWLTQLAERNRQCHPDRTALVDERRSVTWAQFHDRTVELARGLAALGIRRGDRVAVLAQDRIEVVESYFALARLGALFVPLNHSLAVPEVAGIIERVGAVAVLGESALLDRHTSLPASVRIRVPLDKPVFEALGTVDEPVELPEVADTDPVAILHTSATTGQAKGVTVDGGSFRAIALGWLVLARPTDDIVMVNCCPLYHGSMVVSLTYMAAGATIVLMPGFTPQRALAAVEENRATHMWMVPQMVRFMLQAKGSRSTDLGSLREILYGAAPMPLDVYAEAVERLGCGFRQVYGMTEVGGPFVTLGPDEHPEPGDVAARIPCGRVVPGMSARAVGQDGQEVPRGEIGEIVVRGPGVMQGYWNDPEATEEVTADGWVLTGDLGFVDESGRIHLVDRSKDVIIRAGQNVYPSEIERALTAHPDVRDAAVVGVPDEDYGEVPLAYVVVEEGTTTATLLAHVRENLAPYKRPRSFEFIERVPRNPAGKILKKALRT	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	88.49	gnl|BL_ORD_ID|4935|hsp_num:0	5928			141	1632	colistin A; colistin B
BGC0001216.1|Splenocin_9 # 18401 # 18649 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.687	BGC0001216.1|Splenocin_9 	18401	18649	-	Loose	600	23.8682	Streptomyces venezuelae rox	28.21	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCACCATCAGGGAGTTGCTGGTCGAACTCACCGGCACCACCGAGTACGCCGAGACCCTCGGTGACGATGTCGACCTGGCCGGCAGCGGCATCGACTCGGGCGACCTGGTGCGCCTGGTCCTCCTGGTCGAACAGCGCACGGGAGTGGAGATCACCGGGGACGACATGGAGGAGCTGCGGACCATCGCCGACTACGAGCGGTTCGTCGCCGAGCGCACGACGGCCGGGACGGCCGGCGGTGCCTGA	MSTIRELLVELTGTTEYAETLGDDVDLAGSGIDSGDLVRLVLLVEQRTGVEITGDDMEELRTIADYERFVAERTTAGTAGGA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	17.23	gnl|BL_ORD_ID|4833|hsp_num:0	5820			462	690	rifampin; rifaximin; rifapentine
BGC0001216.1|Splenocin_10 # 18950 # 20005 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.750	BGC0001216.1|Splenocin_10 	18950	20005	+	Loose	400	26.5646	JOHN-1	24.69	3000840	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	JOHN beta-lactamase	ATGAGCGGCGCACCGGCGCGGGCGACGGCCTCTCCGGCCGCTGACGCAGAGGCGGCGTCGCAGGCCCGGCTCACCGCCGAGTTCGAGGCGCTGCTCGCCGAGGGCGAGACGGTCGAGCCCCGGGACTGGATGCCGGACGGCTACCGCCGCATGCTGATCCGGCAGATCGCCCAGCACGCGCACTCCGAGATCATCGGCATGCAGCCGGAGGGCGCCTGGCTGACCCGGGCACCCTCGCTGCACCGGAAGTCCGTCCTGCTGGCGAAGGTCCAGGACGAGGCGGGCCACGGCCTGTACCTGTACTCGGCGGCCGAGACGCTGGGCGTGGACCGCGCGGAGTTGCTGGCGGCCCTGCACCGGGGCCAGCAGCGGTACGCGGCGACCTTCAACCACCCGGCACTGACCTGGGCCGACACCGGGGCCGTCGCCTGGTTGACGGACGGCGCCGCGGTGATCAACCAGGCGCCGCTGTGCCACACCTCGTACGGGCCCTACGCGCGGGCCATGCGCCGGGTGTGCCAGGAGGAGGCGTTCCACGTGCGGCAGGGGTACGACCTGATGAAGGCCCTCTGTGAGGGCACGCCCGCGCAGAAGGCGATGGCGCAGGACGCGGTGGACCGCTGGTGGCTGCCGGCGGTGGCGCTGATGTTCGGGCCGCCGGACACGGAGGCGGCCGGCGGCGACGCCCGGACGGCCGCGCTCGGAGCGGCGGTCTCCCGCCGGGCCATCGCGTGGGGCATCAAGCGGCACACCAACGACGAGCTGCGCCAGCGGTTCGTCGACCACTGCGTGCCGCAGGCAAAACGCCTCGGCCTGACCCTGCCCGACCCGGGCATCCGCTGGAACGAGGAGCGCGGGCACTACGACTTCGGTCCCGTCGACTGGGAGCTGTACCGGGGCGCGCTGGGCGACGACACGCACACCGCCCGGCAGCGGCTGGCCCACCGGGTCGCCGCGCACGAGGACGGCGCGTGGGTCCGGGAGGCGGCCGCCGCGTACGCGGCGCGGCAGTCCGGCGAGGACACGGCGGGCACGAGCACGGAGGCGGTGGCGTGA	MSGAPARATASPAADAEAASQARLTAEFEALLAEGETVEPRDWMPDGYRRMLIRQIAQHAHSEIIGMQPEGAWLTRAPSLHRKSVLLAKVQDEAGHGLYLYSAAETLGVDRAELLAALHRGQQRYAATFNHPALTWADTGAVAWLTDGAAVINQAPLCHTSYGPYARAMRRVCQEEAFHVRQGYDLMKALCEGTPAQKAMAQDAVDRWWLPAVALMFGPPDTEAAGGDARTAALGAAVSRRAIAWGIKRHTNDELRQRFVDHCVPQAKRLGLTLPDPGIRWNEERGHYDFGPVDWELYRGALGDDTHTARQRLAHRVAAHEDGAWVREAAAAYAARQSGEDTAGTSTEAVA	MRKLASIILFLAAVSNSLGQSKNSPLQISHLTGDFYVYRTFNDYKGTKISANAMYVVTDKGVVLFDAPWDKTQFQPLLDSIKAKHNKEVVMLFGTHSHEDRAGGFDFYKKKGIKTYSIKLTDDILKKNKEPRAEFIISNDTTFTVGNHTFEVYYPGKGHAPDNIVAWFKKEKILYGGCFVKSAEALDLGYLGDADVKEWQKSIKKVQAKFKKPDYIISGHDDWTSKESLNHTLKLVDEYLAQKSAGKK	141.53	gnl|BL_ORD_ID|297|hsp_num:0	222			24	267	
BGC0001216.1|Splenocin_12 # 20297 # 21085 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=8bp;gc_cont=0.749	BGC0001216.1|Splenocin_12 	20297	21085	+	Loose	500	27.7202	leuO	43.9	3003843	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTGAGACGGCGACCGGGCCGGCCCGGCAGGGTACGGACGCCGCGCTGGCGCGGTACGCGGTGCGGCTCGGTGACGACGCGCTGGTGCTCGCGCAGCAGTTGTGCGGGTGGATCACCAGGGCGCCAACCATCGAGGAGGATCTGGCGCTCTCCAACATCGCGCTCGACCTGGTCGGCCATGCCCGGACCCTGCTGGCCCTCGGCGGGCGCCTGGACGGCACCGGCCGTACCGAGGACGACTTCGCGTTCCTGCGCACGGAACGGGAGTTCACCAACGCGCTGCTCGTCGAGATCCCGGACGGCGACTTCGCCGGGACGGTGGCACGGCAGCTCGCCTACACCCACCACGCCGTGCTCCTGTACGAGGCCCTGGCCGCGAGTACGGACCCGGAGCTGGCGGCGTTCGCGGTCCGGGCGGCCAAGGAGGTCGCCTACCACCGGCGGCACGCCGACGACTGGGTCGTCCGGCTGGGCCTGGGCACCGCGGAGAGCGCGCGGCGGATGCGGGCGGGGCTGGAGCGGGTGTGGCCGTGCACGGCCGAACTCTTCGAGGAGGACGCGCTGGTGCGCGGGCTCACCGCGGCCGGTGCCGTGCCCGCACCGGGCCCGCTGCGCGAACGCTGGCACGAGGAGGTGGCGGCCGTGCTGGAGCGGGCCGGTCTGCCGCTCCCCGCGCCGACGTGGCACGCCGCCGGAGGCCGCGACGGCCTGCACACCGAGGCGTTCGGCCCGCTGGTGGCCGAACTCCAGTCGGTCCACCGGCAGTTCCCGGGAGGCACGTGGTGA	MTETATGPARQGTDAALARYAVRLGDDALVLAQQLCGWITRAPTIEEDLALSNIALDLVGHARTLLALGGRLDGTGRTEDDFAFLRTEREFTNALLVEIPDGDFAGTVARQLAYTHHAVLLYEALAASTDPELAAFAVRAAKEVAYHRRHADDWVVRLGLGTAESARRMRAGLERVWPCTAELFEEDALVRGLTAAGAVPAPGPLRERWHEEVAAVLERAGLPLPAPTWHAAGGRDGLHTEAFGPLVAELQSVHRQFPGGTW	MPEVQTDHPETAELSKPQLRMVDLNLLTVFDAVMQEQNITRAAHALGMSQPAVSNAVARLKVMFNDELFVRYGRGIQPTARAFQLFGSVRQALQLVQNELPGSGFEPASSERVFHLCVCSPLDSILTSQIYNHIEQIAPNIHVMFKSSLNQNTEHQLRYQETEFVISYEDFHRPEFTSVPLFKDEMVLVASKNHPTIKGPLLKHDVYNEQHAAVSLDRFASFSQTWYDTVDKQASIAYQGMAMMSVLSVVSQTHLVAIAPRWLAEEFAESLELQVLPLPLKQNSRTCYLSWHEAAGRDKGHQWMEEQLVSICKR	83.44	gnl|BL_ORD_ID|4926|hsp_num:0	5921			780	903	acriflavine; puromycin
BGC0001216.1|Splenocin_14 # 21612 # 22715 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.762	BGC0001216.1|Splenocin_14 	21612	22715	+	Loose	1800	30.8018	mdtC	34.0	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACACTGCGGTCCCGAGGGCGGCGCAGACGGCGCCCCCGCGCAACAGCTGGTACCCGCTGCCGGTCACCCTGCTCGACCGGCTCACCGAGGACACCGTCGCGATCACCCTGGAGGTTCCGGACGGCCTGCGCGAGCGGTTCGTCCACCGGCCCGGCGCCCACGTCGTCGTCCGGCACCGGACCGGCGGCCGGGAACTGCGCCGCAGTTACTCGGTGTGCCCGCCGCCCGAGGACCCGGCGGCGCTGCGGCTGGTGGTCAAGCGCAACACCTCCGACGGTTTCGGCGCGCACGCCCTGGAACGGCTCGCGGCCGGTGACCTCCTGGAGGTGGGTCCGCCTGCCGGCCACTTCGGGCTGCCGCCGGTACGCGGCGCGCACCACCTGCTGATCGCCGGAGGCTGCGGCATCACGCCGCTGGCTCCGATGGCGGCGGCCGCGTTGCGGGAGGACCCGACGTGCCGGGTCTCCCTGGTGCACGCGGCGCGCACCGCCCGGGGCGCCCTGCTGGCCGACGAGATGGCCGTGCTGAAGGACGCGTACGTCGACCGCTTCACCGCGCTGTACGTGCTCTCCCGCGAACGGCGCGAGACCGAGCTGTTCAGCGGCCGGATCGACGCCGGCCGGCTGACGCGGCTGCTGACCCTGCTGGGCGCCCGGCCCGGCCCCGCGACCCGGTTCGCGGTGTGCGGTCCGTACGGCCTGGTGGAGACGGTCCGCTCCACGCTCGACGGGTGGGGGGCCGAGCCGGACACCGTCCGTTTCGAGCTGTTCTCCACCGACGGGGCGCCGCCGGAGCCCGAGGCCGAGGCGCCCGCCGTCCGCAGGGGCCGGATCACCACCGTGCTCGCCGGGCGCACCGGCACGGTGACGACAGCGCCGGAGGACACCACGCTCCTCGACACCGTGCTGCGGTCCCGGCCCGACGCGCCGTACGCCTGCCGTGACGGGGTGTGCGGGAACTGCCGCGCCAAGGTCGTCCGGGGGGCCGTGACCCTCGGCCGGCAGCACGCGCTGGACGCGGCCGACCTCGCGGCGGGCTACACCCTCGCGTGCCGGGCCCGGCCGCGCACCGACGACGTGACGCTCGACTTCGACGCCTGA	MDTAVPRAAQTAPPRNSWYPLPVTLLDRLTEDTVAITLEVPDGLRERFVHRPGAHVVVRHRTGGRELRRSYSVCPPPEDPAALRLVVKRNTSDGFGAHALERLAAGDLLEVGPPAGHFGLPPVRGAHHLLIAGGCGITPLAPMAAAALREDPTCRVSLVHAARTARGALLADEMAVLKDAYVDRFTALYVLSRERRETELFSGRIDAGRLTRLLTLLGARPGPATRFAVCGPYGLVETVRSTLDGWGAEPDTVRFELFSTDGAPPEPEAEAPAVRRGRITTVLAGRTGTVTTAPEDTTLLDTVLRSRPDAPYACRDGVCGNCRAKVVRGAVTLGRQHALDAADLAAGYTLACRARPRTDDVTLDFDA	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	35.80	gnl|BL_ORD_ID|1212|hsp_num:0	1315			1872	2022	novobiocin
BGC0001216.1|Splenocin_16 # 23573 # 24421 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.713	BGC0001216.1|Splenocin_16 	23573	24421	+	Loose	650	28.8758	ALG6-1	35.19	3006893	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG6 beta-lactamases	ATGAACGACGGCCCGTCCGCTCTCGCGGAACTCGCCGAGGACACCACGCTGACCCGCCCCTTCTCCGGTGCCAGCCCTTACGAGGAGTACGTCCACGCCTCCGTCCTCAACACGCTGCAACAGCCCCTCACCGAAGCCGCTGACGAGATGGGATTCCTCGTCACCACGCAGGTGATGGAGTTGTGGTTCACCCTGATCGTCCACGAGTGGCGCACGGCGCGCGAGGCGTTCGTCAAGGACGACCTGCCCGCCGCGCTCGACGCCCTGACCCGCAGCCGGCGCGCCCTGTCCGCGCTCAACGACTCCTGGCAGCCGATCGCCGCGCTGACGCCCCTCCAGTTCGAGGGGTTCCGGGCCGCGTTCGGCCGGGCCTCCGGTTTCCAGTCGGCGATGTACCGGCACATCGAGTTCCTGCTCGGCGAGAAGTCGGAGGCCCTGGTGAACGCCCATCGCGGGGACCCGGCCGTCCACGAGGCGCTGCGCGACGCCCACCGCGAGCCGCCCCTCTACGACGAGGTCCTGTGCTTCCTGCACCGCCAGGGCCTGCCCGTCCCGGCGCACGTCCGCGAACGCGACGTGTCCCTCTCCTACACCTCCGACCCGGCCGTGGTGGAACTGTGGCGCGGCGTCTACGCCGGATCGCCGTACGAGGCACCGGCCCTGCTCGCGGAGGCGCTGACCGACATCGCCGAGTTGGTCGCCCGCTGGCGGTTCGACCACCTGATGGTGGTGCGACGGGCCATGGGAGCCAAGCCCGGCAGCGGGGGCACCGCCGGACTGGCCTACCTGGAGCAGCGCGCCCGGCGTGTGGTCTTCCCCGAGCTGTGGGAGGCACGCGGTGCGCTCTAG	MNDGPSALAELAEDTTLTRPFSGASPYEEYVHASVLNTLQQPLTEAADEMGFLVTTQVMELWFTLIVHEWRTAREAFVKDDLPAALDALTRSRRALSALNDSWQPIAALTPLQFEGFRAAFGRASGFQSAMYRHIEFLLGEKSEALVNAHRGDPAVHEALRDAHREPPLYDEVLCFLHRQGLPVPAHVRERDVSLSYTSDPAVVELWRGVYAGSPYEAPALLAEALTDIAELVARWRFDHLMVVRRAMGAKPGSGGTAGLAYLEQRARRVVFPELWEARGAL	MSHGIPCAPSSRMETQMVSKMAMAAILLLAGPTAAAEVTPTTPIVCSMCEGWNRPQKPFKIYGNTWYVGTNDLSALLVTSPNGHVLLDGALPQSAPLIEANIQALGFKLKDVKLILNSHEHFDHAGGIPALQRASGATVAASIRGAKVLRAGTVGKDDPQFDPVKPFFLAKLEKVREVADGETLTAGDLRITAHYTPGHTPGGTSWTWTSCENGRCLNMVYADSLTPVSSEGFRFSGGNGAPDISSAFQATIDKVAALKCDVMVSNHPGFSQVMEKLAARTDANNTFIDPTGCRKYAAAASKRLANRLATEAKQKAAR	88.68	gnl|BL_ORD_ID|3290|hsp_num:0	4359			669	831	
BGC0001216.1|Splenocin_17 # 24411 # 25280 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=6bp;gc_cont=0.734	BGC0001216.1|Splenocin_17 	24411	25280	+	Loose	575	35.4242	AST-1	28.21	3004740	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	AST Beta-lactamase	GTGCGCTCTAGGGTCGTCTCCGCGTTCGCGGCGGAGGAGGAGAAGCGTGTCCTGAGCCTGAAGCCGGTACTGGCGCCTCACCACGGCAGGTACGGCGACCACCCGCACCAGGTCTATGACGCCTGGCCGGCCGAGGACCCGGACGCCCCGCTGGTGATCCTGCTGCACGGCGGGTACTGGCGGTACGACCGGATGCATCTGACGCCGTTCGCCGCCTACCTGGCCGGGCAGGGGCTCTCCACGATGCTCCCCGGGTTCCGCAGGTCGGGCGGGGCGGGGGGATACCCCGAGACCTTCGACGACGTCGCCCGTCTCGTGGACACGCTGCCCGGGGGGCGGCCGTACATCCTCGCCGGGCACTGCTCGGGCGGTCACCTGGCTCTGTGGTGCGCGGCCCGCGGGCTGCTGCCGCCGGGGTCACCGTGGCACACCTCCACGCTCCCCACGAGCGTCCTCGCCCTGGCACCGCTCACCGACCTCGCGGCGACCCGCCGGGACGGGCTGAGCGACGACGCCGCGCTGCAACTGATGGGCGGGGAGGAGGGTTTCGCGGCGCACATGGCATCCGTGGACCCGCTCACCCTGCTCAGCGACGCAGGGACGACAGGAGTACCGACCGTGCTGCTCCACGGCGAGGTGGACGAGGAGGTGCCGCTGACCCAGTTCTCCGACTACGCCGCCGTCCACCACGATCTGCGTACGGTCGTCCTGCCGGGCACGGGGCACTACACGCTCATCGAGCCGGGCGCGCCGGCGGCCCGAGAGGTCGCCGACACGCTGTGGCGGATGGCACGCGAGCAGCGGGGTGCCGGCGCCACGGTGGGCCCCACGGACACGCGGGCCAAGGCGAAGGGCGCCGGCCTCGCCTGA	MRSRVVSAFAAEEEKRVLSLKPVLAPHHGRYGDHPHQVYDAWPAEDPDAPLVILLHGGYWRYDRMHLTPFAAYLAGQGLSTMLPGFRRSGGAGGYPETFDDVARLVDTLPGGRPYILAGHCSGGHLALWCAARGLLPPGSPWHTSTLPTSVLALAPLTDLAATRRDGLSDDAALQLMGGEEGFAAHMASVDPLTLLSDAGTTGVPTVLLHGEVDEEVPLTQFSDYAAVHHDLRTVVLPGTGHYTLIEPGAPAAREVADTLWRMAREQRGAGATVGPTDTRAKAKGAGLA	MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELETTSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSAAELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDATSRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGATRIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAEATRVVVDALG	93.23	gnl|BL_ORD_ID|2556|hsp_num:0	3555			411	762	
BGC0001216.1|Splenocin_6 # 15088 # 16308 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=12bp;gc_cont=0.707	BGC0001216.1|Splenocin_6 	15088	16308	+	Loose	660	43.8986	MexS	22.34	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCAAGGACCTCTACGAACTCGGCGACGCGCCGCCCCTCGGCACCGCGCCGAAGCAGATGTACGCCTCCCTGATCCGCCAGGAACGCTACGGCCGGCCCGTCGACGCCTTCCGCACCGAGGTGGTGGACGTACCGCCCGTGGGCCCCGGGCAGGTGCTCGTCAAGGTGATGGCCGCCGGCGTCAACTACAACAACGTGTGGGCGGCGCTCGGTGAGCCGCTCGACGTGATCGCGGCCCGCCAGAAGCAGGGTGCCACCGAGGACTTCCACATCGGCGGCTCGGACCTGTCGGGCATCGTGTGGGCGGTCGGTGAGGGCGTGAGCCTCAAGCCCGGTGCCGAGGTGGTCGTCCTGGCCTGCCGCTGGGACGAGTCGGCCCAGGACATCCGGCTGGGGGCCGACCCGGTCACCTCCTCCACGCAGCGGGTCTGGGGGTACGAGGAGAACTACGGTTCTTTCGCGCAGTTCGCCGTCGTCGACGAGTACATGTGCCACCCGAAGCCGCAGCGGCTCTCGTGGGCGGCGGCCTCCTGCTACATGGCCACCGCGGCGACCGCCTACCGCCAGCTCTTCGGCTGGGAGCCGCACACCGTACGGCCCGGCGACCCGGTCCTGATCTGGGGCGGCGCCGGCGGTCTCGGCAGTATCGCCATCCAGCTCGTGCGCCATGTCGGCGGGATCCCCGTGGCCGTGGTCTCCAGCGAGGAGCGCGGCGAGTTCTGCGTGCGGCTCGGGGCGAAGGGGTGGATCGACCGGCGCGAGTTCGACCACTGGGGCCGGCTGCCGGACACCACCGACGAGGAGGCGATGAAGAAGTGGCTGGACGGCGCCCGCGCCTTCGGCCGCCGCTTCTGGGAGGTCCTCGGGGAACGCCGCGCACCGCGCATCGTCCTGGAGCACTCGGGTGCCGACACCATCCCGACCTCGATCTACATGGCCGACAACGCGGGCATGGTCGTGATCTGCGGCGGCACGACCGGCTACAACGGGGACGTGGACCTGCGGTTCCTGTGGATGCGGCAGAAGCGCCTGCAGGGCTCGCACGTCGCCAGCGCCCGTGAGGCGCGCGAGATCACGCGGCTGATCGACCAGGGCGCGATCGACCCCTGCCTGTCGCGCACCTTCGGCTTCGAGGAGATCGGGCTGGCCCACCAGCTCATCCACGACAACCAGCACCCCTCGGGCAACATGGCGGTACTGGTGAACGCCACCGAGTAG	VTKDLYELGDAPPLGTAPKQMYASLIRQERYGRPVDAFRTEVVDVPPVGPGQVLVKVMAAGVNYNNVWAALGEPLDVIAARQKQGATEDFHIGGSDLSGIVWAVGEGVSLKPGAEVVVLACRWDESAQDIRLGADPVTSSTQRVWGYEENYGSFAQFAVVDEYMCHPKPQRLSWAAASCYMATAATAYRQLFGWEPHTVRPGDPVLIWGGAGGLGSIAIQLVRHVGGIPVAVVSSEERGEFCVRLGAKGWIDRREFDHWGRLPDTTDEEAMKKWLDGARAFGRRFWEVLGERRAPRIVLEHSGADTIPTSIYMADNAGMVVICGGTTGYNGDVDLRFLWMRQKRLQGSHVASAREAREITRLIDQGAIDPCLSRTFGFEEIGLAHQLIHDNQHPSGNMAVLVNATE	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	119.76	gnl|BL_ORD_ID|1039|hsp_num:0	1041			3	972	ciprofloxacin; trimethoprim; chloramphenicol
